Capital Group Private Client Services Inc. purchased a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 6,354 shares of the biopharmaceutical company’s stock, valued at approximately $1,207,000. Other institutional […]